Over the 20th century, additional treatments were developed and FDA approved for treatment of overweight and obesity, including phentermine, phentermine/topiramate, orlistat, and naltrexone/bupropion
Frozen Zepbound pens should be discarded
Kaiser Permanente Northwest, PA criteria for GLP-1 receptor agonists (reported via primary care PA pathway documentation) Ozempic is FDA-approved for type 2 diabetes glycemic control, cardiovascular risk reduction in T2D patients with known CVD, and CKD progression in T2D patients not for weight loss
HUMs VP of Content, Brooke Danielson, breaks it all down
KD, Knockdown
Secher, Jelsing, Baqueror)